Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-21-000393
Filing Date
2021-04-01
Accepted
2021-04-01 18:41:11
Documents
1
Period of Report
2021-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3680
  Complete submission text file 0000904454-21-000393.txt   5265
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PARATEK PHARMACEUTICALS, INC. 75 PARK PLAZA, 4TH FLOOR BOSTON MA 02116
Business Address
Brenner Randall B. (Reporting) CIK: 0001788249 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36066 | Film No.: 21799873